Stocks Listing
DPH.L

Dechra Pharmaceuticals PLC

Share
DPH.L
$3,689.89 0.49%Last Updated Sep 28 2022 02:57 PM
1D Low / 1D High
Low:$3,575.41
High:$3,725.26
1D
0.49%
5D
-
30D
-
BulletPurple
Market Cap
$4,197,763,738
0.49 %
4.2 B
BulletBlue
Volume 1D
254,742
-
254.7 K
BulletOrange
Circulating Supply
1,137,640 DPH.L
1.1 M

Price Chart

1D
5D
1M
6M
YTD
1Y
MAX
About

Dechra Pharmaceuticals PLC develops, manufactures, regulates, markets, and sells veterinary pharmaceuticals and related products for veterinarians. It operates through three segments: European Pharmaceuticals, North American Pharmaceuticals, and Pharmaceuticals Research and Development. The company offers various endocrinology, dermatology, analgesia and anesthesia, cardiovascular, and critical care products for dogs and cats; water soluble antibiotics, poultry vaccines, and pain management for poultry, pigs, and cattle; and lameness and pain management products for horses and ponies. It also provides pet nutrition products for supporting cats and dogs with various therapeutic conditions, such as allergies, obesity, heart, and kidney diseases. In addition, the company distributes veterinary pharmaceuticals and equipment; offers financial services; markets pet diets; and develops, regulates, manufactures, and markets crop protection. It markets its products through wholesaler and distributor networks. The company operates in the United Kingdom, Germany, rest of Europe, the United States, and internationally. Dechra Pharmaceuticals PLC was incorporated in 1997 and is headquartered in Northwich, the United Kingdom.

Historical data

1D
5D
1M
6M
1Y
MAX
Day
Open - Close
Low/High
Volume
Market Cap
Show More
Market Status
Closed
LSE
London Stock Exchange
GBR
Opens in
15 hours, 27 minutes
Working Hours
Mon-Fri, 07:00 AM - 11:00 AM / 11:02 AM - 03:30 PM
Timezone
GMT+0